SCHEMBL17004253

SCHEMBL17004253

c1cnc(OC2C3CC4CC2CN(C4)C3)nc1

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.33
HTT P42858 1/20 0.33
HSD17B10 Q99714 1/20 0.33
RET P07949 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17004248 0.82 HMOX1 (0.33)
SCHEMBL17004198 0.81 FURIN (0.40) RET
SCHEMBL17004295 0.77 CHRNB2 (0.41) ALDH1A1
SCHEMBL17004243 0.77 S1PR4 (0.33)
SCHEMBL17004184 0.74 MEN1 (0.31) HTT
SCHEMBL17004242 0.74 CHRM2 (0.54)
SCHEMBL20068851 0.73 RET (0.34) RET
SCHEMBL20147708 0.73 RET (0.34) RET
SCHEMBL17004311 0.73 TRPC3 (0.35)
SCHEMBL3825645 0.73 CHRNB2 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2099795-B1 AZAADAMANTANE DERIVATIVES AND THEIR USES AS NICOTINIC ACETYLCHOLINE RECEPTORS LIGANDS ABBVIE BAHAMAS LTD (BS) 2015-08-19 EP disclosed